Please Wait.....
Report
Global In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030
Market Report I 2023-06-01 I 390 Pages I Data Bridge Market Research
The global In-vitro toxicology testing market is expected to reach USD 27,952.36 Million by 2030 from USD 11,106.53 Million in 2022, growing at a CAGR of 12.3% during the forecast period of 2023 to 2030.
Market Segmentation
Global In-Vitro Toxicology Testing Market, By Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (Adme (Absorption, Distribution, Metabolism, & Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, & Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture Technologies, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics & Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, U.A.E., and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Global In-Vitro Toxicology Testing Market Dynamics :
Driver
- Increasing demand for toxicology testing products
Restraint
- High cost associated with in-vitro toxicology testing and products
Opportunity
- Rapidly growing pharmaceutical and medical device industries
Market Players
Some of the major market players operating in the global in-vitro toxicology testing market are:
- Thermo Fisher Scientific Inc.
- Labcorp Drug Development
- Merck KGaA
- Charles River Laboratories
- Lonza
- Eurofins Scientific
- SGS Societe Generale de Surveillance SA
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Cyprotex Plc.
- Intertek Group plc
- Promega Corporation
- Catalent, Inc
- Gentronix
- MB Research Laboratories
- BioIVT
- Creative Biolabs
- Aragen Life Sciences Ltd.
- Shanghai Medicilon Inc.
- Creative Bioarray
- InSphero
- IONTOX
- Preferred Cell Systems
- AAT Bioquest, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 41
1.3 OVERVIEW OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET 41
1.4 CURRENCY AND PRICING 43
1.5 LIMITATIONS 43
1.6 MARKETS COVERED 43
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 DBMR TRIPOD DATA VALIDATION MODEL 49
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 52
2.6 MULTIVARIATE MODELLING 53
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE 53
2.8 MARKET END USER COVERAGE GRID 54
2.9 DBMR MARKET POSITION GRID 55
2.10 VENDOR SHARE ANALYSIS 56
2.11 SECONDARY SOURCES 57
2.12 ASSUMPTIONS 57
3 EXECUTIVE SUMMARY 58
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 64
4.2 PORTERS ANALYSIS 65
5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS 66
6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS 68
7 MARKET OVERVIEW 71
7.1 DRIVERS 73
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS 73
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES 73
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS 74
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS 74
7.2 RESTRAINTS 75
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS 75
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS 75
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE 76
7.3 OPPORTUNITIES 76
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS 76
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION 77
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY 77
7.4 CHALLENGES 78
7.4.1 ETHICAL AND PUBLIC PERCEPTION 78
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS 78
8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE 79
8.1 OVERVIEW 80
8.2 CONSUMABLES 83
8.3 SERVICES 84
8.3.1 CYTOTOXICITY 85
8.3.2 GENE TOXICITY 85
8.3.3 HEPATOTOXICITY 85
8.3.4 OPHTHALMIC TOXICITY 85
8.3.5 CARDIOTOXICITY 85
8.3.6 NEPHROTOXICITY 85
8.3.7 NEUROTOXICITY 86
8.3.8 OTHERS 86
8.4 ASSAYS 86
8.4.1 CELL-BASED ELISA & WESTERN BLOTS 87
8.4.2 ENZYME TOXICITY ASSAYS 87
8.4.3 RECEPTOR-BINDING ASSAYS 87
8.4.4 BACTERIAL TOXICITY ASSAYS 87
8.4.5 TISSUE CULTURE ASSAYS 87
8.4.6 OTHER ASSAYS 87
8.5 EQUIPMENTS 88
8.6 SOFTWARE 89
9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST 90
9.1 OVERVIEW 91
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING 94
9.3 CYTOTOXICITY TESTING 95
9.4 GENOTOXICITY TESTING 96
9.5 DERMAL TOXICITY TESTING 97
9.6 OCULAR TOXICITY TESTING 98
9.7 ORGAN TOXICITY TESTING 99
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING 100
9.9 PHOTOTOXICITY TESTING 100
9.10 OTHER TOXICITY ENDPOINTS AND TESTS 101
10 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY 103
10.1 OVERVIEW 104
10.2 CELL CULTURE TECHNOLOGIES 107
10.3 HIGH-THROUGHPUT TECHNOLOGIES 108
10.4 MOLECULAR IMAGING 109
10.5 OMICS TECHNOLOGY 110
11 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD 111
11.1 OVERVIEW 112
11.2 CELLULAR ASSAYS 114
11.3 BIOCHEMICAL ASSAYS 115
11.4 EX-VIVO MODELS 116
11.5 IN SILICO MODELS 117
12 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY 119
12.1 OVERVIEW 120
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 123
12.2.1 CONSUMABLES 124
12.2.2 SERVICES 124
12.2.3 ASSAYS 124
12.2.4 EQUIPMENTS 124
12.2.5 SOFTWARE 124
12.3 DIAGNOSTICS 124
12.3.1 CONSUMABLES 126
12.3.2 SERVICES 126
12.3.3 ASSAYS 126
12.3.4 EQUIPMENTS 126
12.3.5 SOFTWARE 126
12.4 FOOD 126
12.4.1 CONSUMABLES 127
12.4.2 SERVICE 127
12.4.3 ASSAYS 127
12.4.4 EQUIPMENTS 128
12.4.5 SOFTWARE 128
12.5 CHEMICALS 128
12.5.1 CONSUMABLES 129
12.5.2 SERVICES 129
12.5.3 ASSAYS 129
12.5.4 EQUIPMENTS 129
12.5.5 SOFTWARE 129
12.6 COSMETICS AND HOUSEHOLD PRODUCTS 130
12.6.1 CONSUMABLES 131
12.6.2 SERVICES 131
12.6.3 ASSAYS 131
12.6.4 EQUIPMENTS 131
12.6.5 SOFTWARE 131
13 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL 132
13.1 OVERVIEW 133
13.2 DIRECT TENDER 135
13.3 RETAIL SALES 136
13.4 OTHERS 137
14 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION 139
14.1 OVERVIEW 140
14.2 NORTH AMERICA 145
14.2.1 U.S. 154
14.2.2 CANADA 159
14.2.3 MEXICO 164
14.3 EUROPE 169
14.3.1 GERMANY 178
14.3.2 U.K. 183
14.3.3 FRANCE 188
14.3.4 ITALY 193
14.3.5 RUSSIA 198
14.3.6 SPAIN 203
14.3.7 NETHERLANDS 208
14.3.8 2.8 SWITZERLAND 213
14.3.9 BELGIUM 218
14.3.10 TURKEY 223
14.3.11 REST OF EUROPE 228
14.4 ASIA PACIFIC 229
14.4.1 CHINA 238
14.4.2 JAPAN 243
14.4.3 INDIA 248
14.4.4 AUSTRALIA 253
14.4.5 SOUTH KOREA 258
14.4.6 INDONESIA 263
14.4.7 PHILIPPINES 268
14.4.8 THAILAND 273
14.4.9 MALAYSIA 278
14.4.10 SINGAPORE 283
14.4.11 REST OF ASIA-PACIFIC 288
14.5 SOUTH AMERICA 289
14.5.1 BRAZIL 298
14.5.2 ARGENTINA 303
14.5.3 REST OF SOUTH AMERICA 308
14.6 MIDDLE EAST AND AFRICA 309
14.6.1 SAUDI ARABIA 318
14.6.2 SOUTH AFRICA 323
14.6.3 U.A.E. 328
14.6.4 EGYPT 333
14.6.5 ISRAEL 338
14.6.6 REST OF MIDDLE EAST AND AFRICA 343
15 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE 344
15.1 COMPANY SHARE ANALYSIS: GLOBAL 344
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 345
15.3 COMPANY SHARE ANALYSIS: EUROPE 346
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 347
16 SWOT ANALYSIS 348
17 COMPANY PROFILE 349
17.1 THERMO FISHER SCIENTIFIC INC. 349
17.1.1 COMPANY SNAPSHOT 349
17.1.2 REVENUE ANALYSIS 349
17.1.3 COMPANY SHARE ANALYSIS 350
17.1.4 PRODUCT PORTFOLIO 350
17.1.5 RECENT DEVELOPMENT 350
17.2 LABCORP DRUG DEVELOPMENT 351
17.2.1 COMPANY SNAPSHOT 351
17.2.2 REVENUE ANALYSIS 351
17.2.3 COMPANY SHARE ANALYSIS 352
17.2.4 PRODUCT PORTFOLIO 352
17.2.5 RECENT DEVELOPMENT 352
17.3 MERCK KGAA 353
17.3.1 COMPANY SNAPSHOT 353
17.3.2 REVENUE ANALYSIS 353
17.3.3 COMPANY SHARE ANALYSIS 354
17.3.4 PRODUCT PORTFOLIO 354
17.3.5 RECENT DEVELOPMENT 354
17.4 CHARLES RIVER LABORATORIES. 355
17.4.1 COMPANY SNAPSHOT 355
17.4.2 REVENUE ANALYSIS 355
17.4.3 COMPANY SHARE ANALYSIS 356
17.4.4 PRODUCT PORTFOLIO 356
17.4.5 RECENT DEVELOPMENT 356
17.5 LONZA 357
17.5.1 COMPANY SNAPSHOT 357
17.5.2 REVENUE ANALYSIS 357
17.5.3 COMPANY SHARE ANALYSIS 358
17.5.4 PRODUCT PORTFOLIO 358
17.5.5 RECENT DEVELOPMENT 358
17.6 AAT BIOQUEST, INC. 359
17.6.1 COMPANY SNAPSHOT 359
17.6.2 PRODUCT PORTFOLIO 359
17.6.3 RECENT DEVELOPMENTS 359
17.7 ARAGEN LIFE SCIENCES LTD. 360
17.7.1 COMPANY SNAPSHOT 360
17.7.2 REVENUE ANALYSIS 360
17.7.3 PRODUCT PORTFOLIO 361
17.7.4 RECENT DEVELOPMENT 361
17.8 BIOIVT 362
17.8.1 COMPANY SNAPSHOT 362
17.8.2 PRODUCT PORTFOLIO 362
17.8.3 RECENT DEVELOPMENT 362
17.9 BIO-RAD LABORATORIES, INC. 363
17.9.1 COMPANY SNAPSHOT 363
17.9.2 REVENUE ANALYSIS 363
17.9.3 PRODUCT PORTFOLIO 364
17.9.4 RECENT DEVELOPMENT 364
17.10 CATALENT, INC 365
17.10.1 COMPANY SNAPSHOT 365
17.10.2 REVENUE ANALYSIS 365
17.10.3 PRODUCT PORTFOLIO 366
17.10.4 RECENT DEVELOPMENT 366
17.11 CREATIVE BIOARRAY. 367
17.11.1 COMPANY SNAPSHOT 367
17.11.2 PRODUCT PORTFOLIO 367
17.11.3 RECENT DEVELOPMENTS 367
17.12 CREATIVE BIOLABS. 368
17.12.1 COMPANY SNAPSHOT 368
17.12.2 PRODUCT PORTFOLIO 368
17.12.3 RECENT DEVELOPMENTS 368
17.13 CYPROTEX LIMITED 369
17.13.1 COMPANY SNAPSHOT 369
17.13.2 PRODUCT PORTFOLIO 369
17.13.3 RECENT DEVELOPMENT 369
17.14 EUROFINS SCIENTIFIC 370
17.14.1 COMPANY SNAPSHOT 370
17.14.2 REVENUE ANALYSIS 370
17.14.3 PRODUCT PORTFOLIO 371
17.14.4 RECENT DEVELOPMENT 371
17.15 GENTRONIX 372
17.15.1 COMPANY SNAPSHOT 372
17.15.2 PRODUCT PORTFOLIO 372
17.15.3 RECENT DEVELOPMENT 372
17.16 IONTOX 373
17.16.1 COMPANY SNAPSHOT 373
17.16.2 PRODUCT PORTFOLIO 373
17.16.3 RECENT DEVELOPMENT 373
17.17 INSPHERO. 374
17.17.1 COMPANY SNAPSHOT 374
17.17.2 PRODUCT PORTFOLIO 374
17.17.3 RECENT DEVELOPMENT 374
17.18 INTERTEK GROUP PLC 375
17.18.1 COMPANY SNAPSHOT 375
17.18.2 REVENUE ANALYSIS 375
17.18.3 PRODUCT PORTFOLIO 376
17.18.4 RECENT DEVELOPMENT 376
17.19 MB RESEARCH LABORATORIES 377
17.19.1 COMPANY SNAPSHOT 377
17.19.2 PRODUCT PORTFOLIO 377
17.19.3 RECENT DEVELOPMENTS 377
17.20 PREFERRED CELL SYSTEMS 378
17.20.1 COMPANY SNAPSHOT 378
17.20.2 PRODUCT PORTFOLIO 378
17.20.3 RECENT DEVELOPMENTS 378
17.21 PROMEGA CORPORATION 379
17.21.1 COMPANY SNAPSHOT 379
17.21.2 PRODUCT PORTFOLIO 379
17.21.3 RECENT DEVELOPMENTS 380
17.22 QIAGEN 381
17.22.1 COMPANY SNAPSHOT 381
17.22.2 REVENUE ANALYSIS 381
17.22.3 PRODUCT PORTFOLIO 382
17.22.4 RECENT DEVELOPMENTS 382
17.23 SGS SOCIETE GENERALE DE SURVEILLANCE SA 383
17.23.1 COMPANY SNAPSHOT 383
17.23.2 REVENUE ANALYSIS 383
17.23.3 PRODUCT PORTFOLIO 384
17.23.4 RECENT DEVELOPMENTS 384
17.24 SHANGHAI MEDICILON INC. 385
17.24.1 COMPANY SNAPSHOT 385
17.24.2 REVENUE ANALYSIS 385
17.24.3 PRODUCT PORTFOLIO 386
17.24.4 RECENT DEVELOPMENT 386
18 QUESTIONNAIRE 387
19 RELATED REPORTS 390
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security